Sharekhan

Solara Active Pharma Sciences Ltd

Thu 13/03/2025,15:52:59 NSE: SOLARA

₹ 478.75 -10.75 (-2.20%)
BUY NOW Buy Solara Active Pharma Sciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Solara Active Pharma Sciences Ltd

Thu 13/03/2025,0:0:0

Solara Active Pharma Sciences Ltd

Thu 13/03/2025,15:52:59 | NSE : SOLARA

₹ 478.75-10.75 (-2.20%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 490.05

Previous Close

₹ 489.50

Volume

67601

Mkt Cap ( Rs. Cr)

₹1927.15

High

₹ 500.05

Low

₹ 475.35

52 Week High

₹ 882.80

52 Week Low

₹ 360.08

Book Value Per Share

₹ 270.47

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Solara Active Pharma Sciences Ltd

Your Vote -

Buy

88.24%

Hold

5.29%

Sell

6.47%

88.24%

170 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

478.75

306

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

306

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Solara Active Pharma Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Solara Active Pharma - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 Feb 2025, 6:24PM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Shar

  • Solara Active Pharma - Updates

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 3,50,000 ESOP as per the Solara ESOP 2024.

  • Solara Active Pharma - General Updates

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Closure of Wholly Owned Subsidiary, Solara Active Pharma Sciences LTDA, Braz

  • Solara Active Pharma - Change in Management

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange about change in Chief Financial Officer (i.e.) from Resignation of Mr. Arun Kumar Bask

  • Solara Active Pharma - Change in Director(s)

    21 Feb 2025, 6:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Solara Active Pharma - Grant Of ESOP Options

    21 Feb 2025, 5:58PM Solara Active Pharma Sciences Limited has informed the Exchange about Grant of ESOP Options.

  • Solara Active Pharma - Closure Of Wholly Owned Subsidiary

    21 Feb 2025, 5:52PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Closure of Wholly Owned Subsidiary of the Company.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

    21 Feb 2025, 5:39PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Resignation of Managing Director.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    21 Feb 2025, 5:33PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment and Resignation of Chief Executive officer, Appointment and Resi

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate

    21 Feb 2025, 5:24PM Solara Active Pharma Sciences has informed the Exchange regarding the appointment of a Managing Director.

  • Solara Active Pharma - Outcome of Board Meeting

    21 Feb 2025, 5:21PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on February 21, 2025.

  • Solara Active Pharma - Outcome of Board Meeting

    21 Feb 2025, 5:16PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider the appointmen

  • Solara Active Pharma - Board Meeting Outcome for Solara Active Pharma Sciences Limited Has Informed The Exchange Regarding Bo

    21 Feb 2025, 5:16PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider Appointment an

  • Solara Active Pharma - Monitoring Agency Report

    10 Feb 2025, 3:08PM Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    10 Feb 2025, 3:04PM Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted.

  • Solara Active Pharma - General Updates

    7 Feb 2025, 10:34AM SOLARA: The Company in their Board Committee Meeting held today (i.e) February 07, 2025, considered the proposal to incorporate a Wholly Owned Subsidi

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates

    7 Feb 2025, 10:32AM The Company in their Board Committee meeting held today (i.e.) February 07, 2025, considered the proposal to Incorporate a wholly - owned subsidiary C

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Jan 2025, 3:33PM Solara Active Pharma Sciences Limited has informed the Exchange about Earnings Call Transcript for the Board Meeting held on January 24, 2025

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    31 Jan 2025, 2:57PM Earnings Call Transcript for the Board Meeting held on January 24, 2025.

  • Solara Active Pharma - Integrated Filing- Financial

    29 Jan 2025, 2:45PM The Company is hereby submitting the Integrated Filing - Financials for the quarter ended December 31, 2024

  • Solara Active Pharma - Integrated Filing (Financial)

    29 Jan 2025, 2:53PM The Company is hereby submitting the Intergrated Filings -Financials for the quarter ended December 31, 2024.

  • Solara Active Pharma - Copy of Newspaper Publication

    25 Jan 2025, 10:04PM Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication published today to consider the Financial Results

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    24 Jan 2025, 5:48PM Solara Active Pharma Sciences Limited has informed the Exchange about Audio Link of Recording of the Financial Results for the quarter ended December

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Jan 2025, 5:36PM Solara Active Pharma Sciences Limited has informed the Exchange about Audio Link of Recording of the Financial Results for the quarter ended December

  • Solara Active Pharma - Statement of deviation(s) or variation(s) under Reg. 32

    24 Jan 2025, 5:07PM Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

  • Solara Active Pharma - Press Release

    24 Jan 2025, 5:07PM Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 24, 2025, titled ""Solara Q3 25 performance""

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Jan 2025, 5:06PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Press Release for the Board Meeting held on January 24, 2025 on Q3 of FY.25

  • Solara Active Pharma posts Q3 net profit of Rs 8.10 cr

    24 Jan 2025, 3:20PM The company reported standalone net profit during the quarter stood at Rs 8.10 crore compared to net loss of Rs 275.33 crore in the previous year quar

  • Solara Active Pharma - Statement Of Deviation And Variation

    24 Jan 2025, 3:16PM Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation of Funds raised through Rights Issue for Quar

  • Solara Active Pharma - General Updates

    24 Jan 2025, 3:05PM Solara Active Pharma Sciences Limited has informed the Exchange about Board Meeting Updates

  • Solara Active Pharma - Financial Results

    24 Jan 2025, 2:46PM Board Meeting Held today interalia to consider and approve the unaudited financial results for the quarter ended December 31, 2024 and other matters.

  • Solara Active Pharma - Financial Result Updates

    24 Jan 2025, 2:42PM Solara Active Pharma Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

  • Solara Active Pharma - Announcement Under Regulation 30 (LODR) - Update

    24 Jan 2025, 2:41PM Solara Active Pharma Sciences Limited has informed the exchange regarding Board Meeting Update

  • Solara Active Pharma - Outcome of Board Meeting

    24 Jan 2025, 2:38PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on January 24, 2025 interalia to consider and approve the

  • Solara Active Pharma - Board Meeting Outcome for Outcome Of The Board Meeting

    24 Jan 2025, 2:35PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on January 24, 2025 interalia to consider and approve the

  • Solara Active Pharma has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    21 Jan 2025, 12:20PM As of December 2024, 37.23% is owned by Indian Promoters and 62.77% by Public. <p align=justify> Top five Promoters holding highest number of shares o

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Jan 2025, 12:21PM Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of meet

  • Solara Active Pharma - Board Meeting Intimation

    16 Jan 2025, 11:56AM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 24-Jan-2025 to inter-alia consider and approve the U

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Jan 2025, 11:50AM The Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Friday, January 24, 2025,

  • Solara Active Pharma - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Scheduled On 24/01/2025,

    16 Jan 2025, 11:44AM Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 ,inter alia, to

  • Solara Active Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    13 Jan 2025, 3:44PM Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the

  • Solara Active Pharma - Trading Window-XBRL

    27 Dec 2024, 11:35AM SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Closure of Trading Window

  • Solara Active Pharma - Trading Window

    27 Dec 2024, 11:23AM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)

  • Solara Active Pharma

    6 Jul 2023 , 10:51AM Solara Active Pharma has agreed to raise funds through the issue of equity shares of FV of Rs. 10 not exceeding Rs. 450 Cr. by the way of rights issue to eligible equity shareholder of the company. We do not have coverage on it.

  • Solara Active Pharma successfully completes EU GMP Inspection

    13 Feb 2023 , 12:14PM Completion of the EU-GMP inspection at the Cuddalore facility of the Company

  • Stock Update: Solara Active Pharma Science

    12 Nov 2021 , 11:50AM Stock Update: Solara Active Pharma Science Q2FY22 Results Update

  • Solara Active Pharma Sciences Q2Fy22 results

    11 Nov 2021 , 5:14PM Solara Active Pharma Sciences Q2Fy22 results – Weak quarter, results missed estimates

  • Solara Active Pharma Sciences: Q1FY22 Results update

    5 Aug 2021 , 10:59AM Solara Active Pharma Sciences Ltd: Q1FY22 Results update - Healthy quarter; Robust outlook

  • Solara Active Pharma Sciences Q1FY2022

    4 Aug 2021 , 3:31PM Solara Active Pharma Sciences Q1FY2022: Healthy quarter; results miss estimates

  • Solara announces CEP for Ranitidine Hydrochloride drug substance restored by EDQM

    2 Jul 2021 , 3:31PM Solara is the first company to have its CEP restored among Ranitidine API manufacturers

  • Solara Active Pharma Sciences

    2 Jul 2021 , 3:19PM Solara Active Pharma Sciences: Has announced that the EDQM ( European Directorate for the Quality of Medicines & HealthCare) has restored is CEP for Ranitidine Hydrochloride drug substance (API). Solara had put in place robust manufacturing and quality processes to mitigate the risks of N-Nitroso Dimethylamine (NDMA) formation in the Ranitidine HCL API and subsequent submission of the pertinent data has fast-tracked the restoration of CEP by EDQM. Solara is the only company to have its CEP for Ranitidine hydrochloride restored, hence positive

  • Solara Active Pharma Sciences

    1 Jun 2021 , 10:27AM The government of India has given approval to four waitlisted firms under the Production Linked Incentive (PLI) scheme for domestic manufacturing of bulk drugs. It envisages setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30.Now the Government has approved the application of 4 wait listed players who were eligible under the scheme. These include Solara Active Pharma Sciences, while the other companies being approved are Rajasthan Antibiotics Ltd, Dhatri Lab Pvt Ltd and Vital Laboratories Pvt Ltd. The products for which the approvals have been given are 1 Cyclohexane Diacetic Acid, Meropenem, Ritonavir and Levofloxacin. The receipt of the approval for PLI scheme is positive for Solara Active Pharma Sciences.

  • Solara Active Pharma Sciences: Q4FY2021 Result Update

    7 May 2021 , 11:10AM Solara Active Pharma Sciences: Q4FY2021 Result Update - Strong quarter; Robust outlook

  • Stock update - Solara Active Pharma Sciences

    13 Apr 2021 , 11:03AM Stock update - Solara Active Pharma Sciences : Synergetic Merger, Earnings accretive

  • Solara Active Pharma Sciences board approves merger of Aurore Life sciences

    12 Apr 2021 , 12:12PM Solara Active, Aurore Life combine to create second largest Pure Play API / CRAMs company in India

  • Solara Active Pharma Sciences

    12 Apr 2021 , 10:18AM Solara Active Pharma Sciences (Solara): Board approves merger of Aurore Life sciences in an all-stock deal; combined entity to be pure play API company of scale with strong presence in key markets, broad product portfolio and could strengthen Solara’s CRAMS business. We believe the merger would be positive as both the business are synergistic and would open up multiple growth avenues and enable to achieve operational efficiencies

  • Solara Active Pharma Sciences

    19 Feb 2021 , 9:09AM As per media news, The promoters along with TPG capital are said to be looking for an exit from the company. The total promoters stake stands at 44% while TPG Group had a stake of around 15%. The stake sale is likely to trigger an open offer.

  • Solara Active Pharma Sciences : Stock Update

    9 Dec 2020 , 12:04PM Solara Active Pharma Sciences : Stock Update – Growth Levers Intact

  • Solara Active Pharma announces interim dividend

    11 Nov 2020 , 12:20PM Solara Active Pharma Sciences board declares interim dividend of Rs. 4

  • Solara Active Pharma reports good Q2 earnings

    30 Oct 2020 , 3:12PM Solara Active Pharma: Strong operating performance leads to PAT beat

  • Solara Active Pharma Sciences

    16 Sep 2020 , 10:08AM Promoters Pronomz Ventures released pledge of 13.18 lakh shares on September 10, 2020. Post the release the proportion of pledged shares stands at 4.7% of the total promoters holdings down from 13%. The release of the pledged shares is positive

  • New Idea - Solara Active Pharma Sciences

    14 Sep 2020 , 11:40AM New Idea - Solara Active Pharma Sciences – Viewpoint - Well placed to harness API opportunities

  • Solara Active Pharma completes USFDA inspection at SRC

    17 Dec 2018 , 11:35AM Solara Research Centre (SRC) completes USFDA Inspection with Zero 483s
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Solara Active Pharma Sciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 1936.8 2504.28 2551.62 2108.49 1677.29
Liabilities 1936.8 2504.28 2551.62 2108.49 1677.29
Equity 36 36 36 35.92 26.85
Gross Profit -95.06 134.04 80.35 385.33 256.53
Net Profit -566.87 -22.21 -58.56 220.96 112.49
Cash From Operating Activities 110.95 156.17 -241.77 154.44 244.09
NPM(%) -43.98 -1.53 -4.61 13.66 8.51
Revenue 1288.92 1443.81 1268.34 1616.88 1321.75
Expenses 1383.98 1309.77 1187.99 1231.55 1065.22
ROE(%) -52.06 -2.03 -5.37 20.29 10.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Aug 2021 3 30 0 1648.75
19 Nov 2020 4 40 0 1095.5
28 Jul 2020 2 20 0 502.4
06 Aug 2019 5 50 0 442.1

Peers

Other companies within the same industry or sector that are comparable to Solara Active Pharma Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 808.20 -1.14 11.41 273.80 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 57.06 -0.77 237.75 997.70 14.01 0.88
Vaishali Pharma Ltd 12.12 -5.90 606.00 514.25 2.31 0.00
Astec Lifesciences Ltd 653.90 -5.55 0.00 940.75 -239.30 0.00

Company Info

Our Company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the RoC. The name of the Company was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC on March 25, 2017. 2019 -Solara Active Pharma Sciences Limited said that, “it has successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s i 2021 -Solara Active Pharma approves acquisition of balance 10.77% stake in Sequent Penems 2023 -Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility

Our Company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the RoC. The name of the Company was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC on March 25, 2017. 2019 -Solara Active Pharma Sciences Limited said that, “it has successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s i 2021 -Solara Active Pharma approves acquisition of balance 10.77% stake in Sequent Penems 2023 -Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility

Read More

Parent Organisation

Solara Active Pharma Sciences Ltd.

Founded

23/02/2017

Managing Director

Mr.Poorvank Purohit

NSE Symbol

SOLARAEQ

FAQ

The current price of Solara Active Pharma Sciences Ltd is ₹ 478.75.

The 52-week high for Solara Active Pharma Sciences Ltd is ₹ 500.05 and the 52-week low is ₹ 475.35.

The market capitalization of Solara Active Pharma Sciences Ltd is currently ₹ 1927.15. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Solara Active Pharma Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Solara Active Pharma Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Solara Active Pharma Sciences Ltd shares.

The CEO of Solara Active Pharma Sciences Ltd is Mr.Poorvank Purohit, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT